Post-Cataract Corneal Decompensation in Fuchs Endothelial Dystrophy
A 74-year-old woman with known Fuchs endothelial dystrophy (central guttata, preoperative central corneal thickness 640 microns) underwent uneventful phacoemulsification with in-the-bag posterior chamber IOL in the right eye 6 weeks ago. She reports persistent blurring and glare worse in the morning. Examination: best-corrected visual acuity 20/80, central microcystic edema with Descemet folds, IOP 16 mmHg, IOL well centered, no inflammation. Pachymetry is now 720 microns centrally. She is using topical prednisolone acetate 1% four times daily and sodium chloride 5% ointment at night, started by the referring ophthalmologist 3 weeks ago. She is eager to know whether she will need another surgery and when she can drive.
1. How would you characterize the cause of her persistent edema, and what features of the history and examination most influence your management?
Read the worked answer
The edema is corneal endothelial decompensation from pre-existing Fuchs dystrophy, unmasked by the additional endothelial stress of cataract surgery, rather than pseudophakic bullous keratopathy from surgical trauma (surgery was uneventful, IOL in the bag, no inflammation).
Key drivers of management:
- Preoperative pachymetry of 640 microns signals limited endothelial reserve; a postoperative rise to 720 at 6 weeks suggests the endothelium is not recovering.
- Persistent, worsening edema at 6 weeks rather than improving: early postoperative edema typically peaks at days and resolves; failure to improve by 4-8 weeks portends chronic decompensation.
- Morning-predominant symptoms are consistent with overnight eyelid closure reducing evaporation and worsening stromal hydration.
- The duration and adequacy of medical therapy matter: hypertonic saline and topical steroid are temporizing, not curative. Prolonged topical steroids without inflammation risk IOP rise and infection, so they should be tapered rather than continued indefinitely.
- IOP must be confirmed (16 mmHg is reassuring) because steroid response can masquerade as or worsen edema.
Conclusion: this is likely irreversible endothelial failure requiring endothelial keratoplasty (DSAEK or DMEK), and medical therapy is a bridge, not a destination.
2. What is your next step in management, and what would you tell her about the likely need for and timing of surgery?
Read the worked answer
Next step: Stop treating this as a self-limited process. Taper the topical steroid to avoid steroid-related complications while acknowledging it may briefly worsen edema; continue hypertonic saline as symptomatic support. Obtain specular microscopy or endothelial cell count if it will change counseling, and measure central corneal thickness serially. Confirm there is no cystoid macular edema or other cause of visual loss (e.g., OCT macula) because her visual potential depends on retinal status. Refer for corneal transplantation assessment.
Counseling points:
- With a pachymetry of 720 and non-resolving edema at 6 weeks, spontaneous clearance is unlikely; endothelial keratoplasty is the probable definitive treatment.
- DMEK generally offers faster and better visual recovery than DSAEK but is more technically demanding and carries higher early rebubble/graft detachment risk; either is reasonable depending on surgeon and graft availability.
- Timing: proceed when edema is visually significant and stable/declining rather than waiting for bullae, but allow a few more weeks only if there is documented improvement. Chronic edema risks subepithelial scarring and permanent visual loss.
- Driving: she should not drive while BCVA is 20/80 with glare; discuss legal visual standards and advise against driving until acuity and glare improve, either with medical optimization or after surgery.
3. If she asks whether the cataract surgery caused this and whether it could have been prevented, how do you respond?
Read the worked answer
Explain honestly and without defensiveness:
- The underlying cause is Fuchs dystrophy, a pre-existing endothelial problem. Cataract surgery did not create the disease, but it reduced already-limited endothelial reserve and precipitated decompensation. This is a recognized risk when preoperative pachymetry is elevated.
- Prevention/mitigation strategies exist and are worth discussing: preoperative recognition of Fuchs with pachymetry and specular microscopy; use of viscoelastic and dispersive agents to protect the endothelium; minimizing ultrasound energy and phaco time; and, in selected cases, combined phacoemulsification with endothelial keratoplasty when endothelial reserve is critically low.
- In her case, the surgery was uneventful, so the outcome reflects biologic reserve rather than surgical error.
- Frame the path forward constructively: endothelial keratoplasty has a good prognosis, and her IOL is already in place, so the graft procedure addresses the remaining problem.
This response balances transparency, appropriate reassurance, and accurate expectation-setting.